Furthermore, clinical studies have found TGF-β promoting CD39 and CD73 expression on MDSCs, which can suppress T cell and NK cell activity, thus contributing to the formation of an immunosuppressive microenvironment and enabling tumor cells to evade immune surveillance (61). The gene discussed is TGFB1; the disease is neoplasm.